Literature DB >> 14114008

POTENTIATION OF ANTICOAGULANTS CAUSED BY PYRAZOLE COMPOUNDS.

S L FOX.   

Abstract

Entities:  

Keywords:  BLOOD CHEMICAL ANALYSIS; CHEMISTRY; CORONARY DISEASE; GOUT; HEMATURIA; OXYPHENBUTAZONE; PHENYLBUTAZONE; TOXICOLOGIC REPORT; URIC ACID; WARFARIN

Mesh：

Substances：

Year:  1964        PMID： 14114008     DOI： 10.1001/jama.1964.03060290124046

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

1.  [Changes in the velocity of drug catabolism and their importance in drug therapy].

Authors:  G F Kahl
Journal:  Klin Wochenschr       Date:  1971-04-01

2.  [Competition phenomena in the binding of drugs to albumin].

Authors:  H Büttner; F Portwich
Journal:  Klin Wochenschr       Date:  1967-03-01

Review 3.  Plasma protein binding displacement interactions--why are they still regarded as clinically important?

Authors:  P E Rolan
Journal:  Br J Clin Pharmacol       Date:  1994-02       Impact factor: 4.335

4.  Drug interactions and lethal drug combinations.

Authors:  A Richens
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1975

Review 5.  Drug interactions and clinical pharmacokinetics.

Authors:  M B Kristensen
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

6.  The effect of multiple doses of donepezil HCl on the pharmacokinetic and pharmacodynamic profile of warfarin.

Authors:  P J Tiseo; K Foley; L T Friedhoff
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

Review 7.  The clinician's approach to drug interactions.

Authors:  H F Morrelli; K L Melmon
Journal:  Calif Med       Date:  1968-11

8.  Interaction of phenylbutazone with racemic phenprocoumon and its enantiomers in rats.

Authors:  W Schmidt; E Jähnchen
Journal:  J Pharmacokinet Biopharm       Date:  1979-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.